+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Imbalance of T cell subsets in cancer patients and its modification with bestatin, a small molecular immunomodifier



Imbalance of T cell subsets in cancer patients and its modification with bestatin, a small molecular immunomodifier



Tohoku Journal of Experimental Medicine 147(2): 125-133



The peripheral T lymphocyte subsets and natural killer (NK) cells of patients with cancer were studied by monoclonal antibody assays in comparison with those of non-cancer individuals. An imbalance of immunoregulatory T cell subsets was frequently found in the group of cancer patients (n = 26), being characterized by a relatively high proportion of OKT8+ cells (45.0 +/- 12.0%, p less than 0.01) and a low OKT4+/OKT8+ ratio (1.29 +/- 0.56, p less than 0.05). T cell level showed no significant difference as assessed by either OKT3 or rosette formation with sheep erythrocytes (E). The effect of bestatin was examined in 10 of these cancer patients. The relative proportion of T cell subsets tended to normalize 2 to 6 weeks after starting the daily doses of 30 mg per body. The mean percentage of OKT8+ cells decreased from 47.2 to 33.4 (p less than 0.01), while the helper to suppressor ratio increased from 1.18 to 1.79 (p less than 0.01). A significant increase was also found in the percentage and number of OKT4+ cells and HNK-1+ cells after the drug administration, while T cell level tended to converge to a normal range.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 005619246

Download citation: RISBibTeXText

PMID: 3909512

DOI: 10.1620/tjem.147.125


Related references

Attempts at restoration of t cell subsets and ratio in immunodepressed cancer patients and aids related complex arc patients with bestatin and zinc gluconate. Investigational New Drugs: 101, 1987

Attempts at restoration of t cell subsets and radio in immunodepressed cancer patients and acquired immune deficiency syndrome related complex patients with bestatin and zinc gluconate. Proceedings Of The American Association For Cancer Research Annual Meeting: 5, 1986

Bestatin (Ubenimex)--a low molecular immunomodifier. Papers from a workshop at the 16th International Congress of Chemotherapy. Jerusalem, June 11-16, 1989. Proceedings. Acta Oncologica 29(6): 793-831, 1990

Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer. Experimental and Therapeutic Medicine 4(2): 226-230, 2012

Allelic imbalance in patients with non-small cell lung cancer. Arkhiv Patologii 75(2): 3-8, 2013

Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines. Biomedicine and Pharmacotherapy 50(6-7): 283-289, 1996

Changes in the immunological parameters after a single dose of forphenicinol, a new small molecular immunomodifier. Tohoku Journal of Experimental Medicine 146(4): 419-427, 1985

Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis. Medical Oncology 30(2): 532-532, 2013

A study on the relationship between the dendritic cell subsets and immunology state of patients with advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 10(5): 425-428, 2007

Imbalance of t cell subsets in patients with chronic lymphatic leukemia. Blut 45(3): 172, 1982

Imbalance of T-cell subsets in Iranian allergic rhinitis patients. Journal of Allergy & Clinical Immunology 95(1 PART 2): 192, 1995

Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition. Clinical Cancer Research 16(18): 4654-4665, 2011

Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck. Cancer Immunology, ImmunoTherapy 55(2): 151-159, 2005

Imbalance of t cell subsets in patients with coronary aneurysms in kawasaki disease. Japanese Circulation Journal 51(7): 751, 1987